The immunostaining in oral squamous cell carcinomas revealed that the TP53 family members are biomarkers that could contribute to the diagnosis and monitoring of high-risk precancerous lesions of the oral epithelium (Bidaud et al., 2010). Here, TP53 is linked to oral cavity squamous cell carcinoma.